Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumococcal Vaccines | 11 | 2016 | 30 | 3.590 |
Why?
|
| Pneumococcal Infections | 5 | 2019 | 30 | 2.100 |
Why?
|
| Vaccination | 6 | 2019 | 189 | 1.590 |
Why?
|
| Streptococcus pneumoniae | 7 | 2014 | 32 | 1.570 |
Why?
|
| Polysaccharides, Bacterial | 5 | 2014 | 31 | 1.470 |
Why?
|
| Antibodies, Bacterial | 10 | 2019 | 90 | 1.400 |
Why?
|
| B-Lymphocytes | 5 | 2013 | 329 | 1.300 |
Why?
|
| HIV Infections | 4 | 2019 | 791 | 0.780 |
Why?
|
| Biological Variation, Population | 1 | 2019 | 8 | 0.660 |
Why?
|
| Antibody Formation | 1 | 2019 | 93 | 0.650 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2019 | 85 | 0.630 |
Why?
|
| Immunity, Active | 1 | 2016 | 2 | 0.540 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2015 | 25 | 0.520 |
Why?
|
| HIV Seropositivity | 1 | 2016 | 66 | 0.520 |
Why?
|
| Polysaccharides | 2 | 2006 | 176 | 0.480 |
Why?
|
| Immunoglobulin M | 2 | 2013 | 172 | 0.460 |
Why?
|
| Chitin | 2 | 2004 | 6 | 0.440 |
Why?
|
| Immunophenotyping | 1 | 2013 | 110 | 0.440 |
Why?
|
| Bacterial Capsules | 1 | 2013 | 8 | 0.440 |
Why?
|
| Antigens, CD | 1 | 2013 | 230 | 0.420 |
Why?
|
| Peptide Library | 3 | 2001 | 16 | 0.400 |
Why?
|
| Neisseria meningitidis | 3 | 2000 | 10 | 0.370 |
Why?
|
| Molecular Mimicry | 2 | 2001 | 13 | 0.370 |
Why?
|
| Inflammation | 1 | 2016 | 1030 | 0.340 |
Why?
|
| Antibody Affinity | 4 | 2019 | 26 | 0.330 |
Why?
|
| Influenza Vaccines | 2 | 2019 | 56 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 7 | 2006 | 532 | 0.300 |
Why?
|
| Peptides | 2 | 2001 | 455 | 0.290 |
Why?
|
| Aging | 2 | 2006 | 911 | 0.290 |
Why?
|
| Vaccines, Conjugate | 4 | 2015 | 11 | 0.290 |
Why?
|
| Adjuvants, Immunologic | 2 | 2004 | 63 | 0.280 |
Why?
|
| Cell Transplantation | 1 | 2006 | 22 | 0.270 |
Why?
|
| Tetanus Toxoid | 2 | 2004 | 11 | 0.260 |
Why?
|
| Poloxamer | 2 | 2004 | 10 | 0.260 |
Why?
|
| Drug Delivery Systems | 2 | 2004 | 236 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 507 | 0.240 |
Why?
|
| Vaccines | 1 | 2004 | 21 | 0.240 |
Why?
|
| Mice | 10 | 2019 | 8474 | 0.220 |
Why?
|
| Adult | 8 | 2019 | 21403 | 0.210 |
Why?
|
| Immunity, Mucosal | 1 | 2001 | 19 | 0.200 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.200 |
Why?
|
| Influenza, Human | 2 | 2019 | 79 | 0.190 |
Why?
|
| Vaccines, DNA | 1 | 2001 | 9 | 0.190 |
Why?
|
| Humans | 13 | 2019 | 68618 | 0.190 |
Why?
|
| Immunodominant Epitopes | 1 | 2000 | 13 | 0.180 |
Why?
|
| Middle Aged | 6 | 2019 | 21147 | 0.180 |
Why?
|
| Immunologic Memory | 2 | 2013 | 75 | 0.170 |
Why?
|
| Bacterial Vaccines | 1 | 2000 | 32 | 0.170 |
Why?
|
| Aged | 5 | 2019 | 14862 | 0.170 |
Why?
|
| Antigens, T-Independent | 1 | 1999 | 1 | 0.170 |
Why?
|
| Cytokines | 2 | 2019 | 866 | 0.170 |
Why?
|
| Young Adult | 3 | 2016 | 5717 | 0.170 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1999 | 28 | 0.170 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 81 | 0.170 |
Why?
|
| Anti-Retroviral Agents | 2 | 2019 | 53 | 0.170 |
Why?
|
| Population Groups | 1 | 2019 | 16 | 0.160 |
Why?
|
| Staphylococcus | 1 | 2019 | 29 | 0.160 |
Why?
|
| Lipoproteins | 1 | 2000 | 161 | 0.160 |
Why?
|
| Age Factors | 2 | 2014 | 1864 | 0.160 |
Why?
|
| Bacterial Translocation | 1 | 2019 | 27 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 98 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 110 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 245 | 0.150 |
Why?
|
| Animals | 10 | 2019 | 20881 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2019 | 285 | 0.140 |
Why?
|
| Male | 7 | 2019 | 37321 | 0.140 |
Why?
|
| Immunoglobulin G | 4 | 2006 | 481 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2000 | 597 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2019 | 434 | 0.140 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2015 | 4 | 0.130 |
Why?
|
| Female | 6 | 2019 | 38074 | 0.130 |
Why?
|
| DNA, Complementary | 2 | 2006 | 251 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2006 | 238 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 180 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2016 | 330 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2001 | 1083 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 1447 | 0.110 |
Why?
|
| Chitosan | 2 | 2004 | 11 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 626 | 0.110 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 53 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 80 | 0.110 |
Why?
|
| Drug Synergism | 2 | 2004 | 260 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2006 | 1664 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 489 | 0.100 |
Why?
|
| Immunization, Secondary | 2 | 2001 | 17 | 0.090 |
Why?
|
| Meningococcal Vaccines | 2 | 2001 | 17 | 0.090 |
Why?
|
| Antibody Specificity | 2 | 2001 | 98 | 0.090 |
Why?
|
| Immunoglobulin A | 2 | 2001 | 79 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 511 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 4848 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 100 | 0.070 |
Why?
|
| Models, Animal | 1 | 2006 | 252 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 226 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.060 |
Why?
|
| Diphtheria Antitoxin | 1 | 2004 | 1 | 0.060 |
Why?
|
| Tetanus Antitoxin | 1 | 2004 | 1 | 0.060 |
Why?
|
| Diphtheria Toxoid | 1 | 2004 | 5 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.060 |
Why?
|
| Gene Expression | 1 | 2006 | 770 | 0.060 |
Why?
|
| Adolescent | 1 | 2015 | 8912 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 597 | 0.050 |
Why?
|
| Base Sequence | 2 | 2001 | 1015 | 0.050 |
Why?
|
| Gels | 1 | 2001 | 55 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2001 | 88 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2001 | 91 | 0.050 |
Why?
|
| Nasal Mucosa | 1 | 2001 | 68 | 0.050 |
Why?
|
| Microspheres | 1 | 2001 | 59 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2001 | 75 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 357 | 0.050 |
Why?
|
| Streptococcus Phages | 1 | 2000 | 1 | 0.040 |
Why?
|
| Blood Bactericidal Activity | 1 | 2000 | 2 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 2000 | 13 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2001 | 312 | 0.040 |
Why?
|
| Bacteriophages | 1 | 2000 | 24 | 0.040 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1999 | 19 | 0.040 |
Why?
|
| Germinal Center | 1 | 2019 | 13 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 72 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 68 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2019 | 59 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 150 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2019 | 156 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1745 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 397 | 0.040 |
Why?
|
| Lung | 1 | 2001 | 849 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1266 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2550 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1988 | 54 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 1988 | 455 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2001 | 5 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2001 | 24 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 302 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 241 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2001 | 1692 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 2791 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 18 | 0.010 |
Why?
|
| Serotyping | 1 | 1988 | 16 | 0.010 |
Why?
|
| Epitopes | 1 | 1988 | 146 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1988 | 69 | 0.000 |
Why?
|